SolidWorld-GROUP-Logo.png

3D bioprinting trasforms medicine

Biomanufacturing is one of the strategic pillars of SolidWorld GROUP‘s innovation, and today additive biotechnology is confirmed as a key element for the development of the first 3D printed organs

RaiNews reported on the Humanitas 3D Innovation Lab project, which has achieved an extraordinary goal: reproducing human organs affected by pathologies to improve pre-operative surgical planning. A true revolution made possible by the integration of cutting-edge technologies in clinical and research laboratories.

Among these, Electrospider stands out, the biofabrication system developed by SolidWorld GROUP together with the Bio3DPrinting biomedical business unit, already chosen by Humanitas to support this innovation.

This is why our commitment continues to focus on technological development and integration, an essential driver for evolution.
Find out more in the RaiNews service.

Related topics: